Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer

Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer

Abstract Evaluating the therapeutic response and survival of lung cancer patients receiving first‐line chemotherapy has always been difficult. Limited biomarkers for evaluation exist and as a result histology represents an empiric tool to guide therapeutic decision making. In this study, molecular s...

Full description

Bibliographic Details
Main Authors: Yayi He, Lele Song, Hao Wang, Peixin Chen, Yu Liu, Hui Sun, Xiaobin Li, Shiying Dang, Guifeng Liu, Xinyi Liu, Shifu Chen, Xiaoni Zhang, Paul Hofman, Junji Uchino, Henry S. Park, Jose M. Pacheco, Fabrizio Tabbò, Mingyan Xu, Jiawei Dai, Kan He, Yang Yang, Caicun Zhou, written on behalf of the AME Lung Cancer Collaborative Group
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Advanced Science
Subjects:
chemotherapy
lung cancer
NSCLC
SCLC
subtype
TMB
Online Access:https://doi.org/10.1002/advs.202003263

Internet

https://doi.org/10.1002/advs.202003263

Similar Items